Cargando…
Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
Anti-melanoma differentiation-associated gene 5 (MDA5) antibodies are specific indicators of patients with dermatomyositis, particularly clinically amyopathic dermatomyositis (CADM). CADM is occasionally accompanied by fatal, treatment-resistant, rapidly-progressive interstitial lung disease (RP-ILD...
Autores principales: | Suzuki, Atsushi, Kondoh, Yasuhiro, Taniguchi, Hiroyuki, Tabata, Kazuhiko, Kimura, Tomoki, Kataoka, Kensuke, Ono, Kenzo, Hashisako, Mikiko, Fukuoka, Junya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910142/ https://www.ncbi.nlm.nih.gov/pubmed/27354955 http://dx.doi.org/10.1016/j.rmcr.2016.05.008 |
Ejemplares similares
-
Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
por: Ishihara, Hiroyuki, et al.
Publicado: (2021) -
Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020) -
Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020) -
Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate
por: Hayashi, Masachika, et al.
Publicado: (2017) -
Amyopathic dermatomyositis with diffuse lung disease
por: Bandi, Sumeera, et al.
Publicado: (2020)